KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in Immune Response - Cellular (9)

Tuesday
Jul232013

NCT01911234

Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis 

Condition: Rheumatoid Arthritis
Sponsor: NeoVacs
Phase: II 

Thursday
Feb142013

NCT01910662

Thursday
Dec012011

NCT01489956

A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)

Conditions: Autoimmune Disorders
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) 
Phase 0 completed

Tuesday
Apr142009

2008-001974-33

mRNA-transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients

Conditions: Uveal Melanoma 
Sponsors: Radboud University Nijmegen Medical Centre
Phase n/a

Tuesday
Mar252008

NCT00643097

Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Conditions: Brain and Central Nervous System Tumors
Sponsors: Duke University, National Institute of Neurological Disorders and Stroke
Phase II

Friday
Apr062007

PA16215

Tuesday
Sep272005

NCT00228189

Carcinoembryonic Antigen-loaded Dendritic Cells in Advanced Colorectal Cancer Patients

Conditions: Colorectal Cancer, Liver Metastases
Sponsors: Radboud University
Phase I, II

Tuesday
Aug232005

NCT00135681

Immune Dysregulation in Children and Adults With Asthma

Conditions: Asthma, Lung Diseases
Sponsors: National Heart, Lung, and Blood Institute (NHLBI)
Phase n/a 

Wednesday
Jan292003

NCT00053430

Using the Drug Thalidomide to Stimulate T Cells in HIV-Infected People

Conditions: HIV Infections
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
Phase II